MX2015003368A - Metodos para modular los niveles de corticosterona en individuos psicologicamente estresados. - Google Patents

Metodos para modular los niveles de corticosterona en individuos psicologicamente estresados.

Info

Publication number
MX2015003368A
MX2015003368A MX2015003368A MX2015003368A MX2015003368A MX 2015003368 A MX2015003368 A MX 2015003368A MX 2015003368 A MX2015003368 A MX 2015003368A MX 2015003368 A MX2015003368 A MX 2015003368A MX 2015003368 A MX2015003368 A MX 2015003368A
Authority
MX
Mexico
Prior art keywords
methods
modulating
corticosterone levels
stressed individuals
individual
Prior art date
Application number
MX2015003368A
Other languages
English (en)
Other versions
MX369453B (es
Inventor
Maria Ramirez Gonzalez
Enrique Vazquez Hernandez
Ricardo Rueda Cabrera
Rachael Buck
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46940436&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015003368(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2015003368A publication Critical patent/MX2015003368A/es
Publication of MX369453B publication Critical patent/MX369453B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describen los métodos para modular y/o para disminuir los niveles de la corticosterona sérica en un individuo afectado por el estrés. Además se describen los métodos para modular la respuesta hipotalámica-hipofisaria-suprarrenal en un individuo. Los métodos incluyen administrar la 2-fucosil-lactosa a un individuo.
MX2015003368A 2012-09-14 2013-09-12 Composiciones nutricionales para modular los niveles de corticosterona en individuos psicologicamente estresados. MX369453B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382354.4A EP2708145B1 (en) 2012-09-14 2012-09-14 Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
PCT/US2013/059436 WO2014043330A1 (en) 2012-09-14 2013-09-12 Methods for modulating corticosterone levels in psychologically stressed individuals

Publications (2)

Publication Number Publication Date
MX2015003368A true MX2015003368A (es) 2015-10-22
MX369453B MX369453B (es) 2019-11-08

Family

ID=46940436

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015003368A MX369453B (es) 2012-09-14 2013-09-12 Composiciones nutricionales para modular los niveles de corticosterona en individuos psicologicamente estresados.

Country Status (14)

Country Link
US (3) US10398716B2 (es)
EP (1) EP2708145B1 (es)
CN (1) CN104780781B (es)
BR (1) BR112015005758A2 (es)
CA (1) CA2884487C (es)
DK (1) DK2708145T3 (es)
ES (1) ES2572831T3 (es)
HK (1) HK1195856A1 (es)
IL (1) IL237589A0 (es)
MX (1) MX369453B (es)
MY (1) MY182944A (es)
PH (1) PH12015500545A1 (es)
SG (1) SG11201501976SA (es)
WO (1) WO2014043330A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2708147B1 (en) 2012-09-14 2020-03-11 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose
ES2572831T3 (es) * 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
TW201438719A (zh) 2012-12-18 2014-10-16 Abbott Lab 改善壓力症狀之母乳寡糖
ES2708771T3 (es) * 2012-12-20 2019-04-11 Abbott Lab Formulaciones nutricionales que usan oligosacáridos de leche humana para modular la inflamación
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN115350200A (zh) 2014-12-08 2022-11-18 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US20160287637A1 (en) * 2014-12-08 2016-10-06 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3368047B1 (en) 2015-10-28 2023-04-26 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10835545B2 (en) 2015-10-28 2020-11-17 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
WO2017215722A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic composition comprising hmo and method for modulating emotion and mood disorders
WO2018157900A1 (en) * 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
US20180333426A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
MX2020012783A (es) * 2018-06-25 2021-01-20 Nestle Sa Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion serotonergica en el sistema nervioso central.
WO2024052406A1 (en) * 2022-09-06 2024-03-14 Inbiose N.V. Baked nutritional compositions comprising human milk oligosaccharides

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694181B2 (en) * 1994-03-09 1998-07-16 Abbott Laboratories Humanized milk
US5891689A (en) 1994-04-12 1999-04-06 Innovir Laboratories, Inc. Heme-bearing microparticles for targeted delivery of drugs
KR970706271A (ko) 1994-09-20 1997-11-03 스티븐슨 린다 에스. 시냅스 전달 향상용 약제(drugs to improve synaptic transmission)
RU2199317C2 (ru) 1997-02-21 2003-02-27 Абботт Лаборэтриз Способ снижения заболеваемости некротическим энтероколитом у детей (варианты)
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US20110104716A1 (en) 2003-08-08 2011-05-05 Hasan Mohejeri Novel method for screening brain-active compounds
WO2008011538A2 (en) 2006-07-19 2008-01-24 The Salk Institute For Biological Studies Methods of using flavonoids to enhance memory
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
MX2011004142A (es) * 2008-11-03 2011-05-25 Nestec Sa Una composicion nutricional que comprende probioticos y que mejora los patrones de sueño.
CN102459295A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
EP2451462B1 (en) * 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
RU2530641C2 (ru) 2009-07-15 2014-10-10 Н.В. Нютрисиа Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой
EP3338784B1 (en) 2010-12-31 2020-07-22 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
CA2822660C (en) 2010-12-31 2021-09-07 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides
MX352040B (es) * 2010-12-31 2017-11-07 Abbott Lab Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
WO2012092156A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CN103379908B (zh) * 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
EP3335576A1 (en) 2010-12-31 2018-06-20 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
CN104126749A (zh) 2011-02-10 2014-11-05 雀巢产品技术援助有限公司 使用人乳中发现的特定量的寡糖的组合调节双歧杆菌属的生长
ES2601891T3 (es) 2011-10-18 2017-02-16 Nestec S.A. Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2708147B1 (en) 2012-09-14 2020-03-11 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose

Also Published As

Publication number Publication date
SG11201501976SA (en) 2015-04-29
US20210401862A1 (en) 2021-12-30
US20150238508A1 (en) 2015-08-27
WO2014043330A1 (en) 2014-03-20
US11116779B2 (en) 2021-09-14
CA2884487C (en) 2017-08-29
IL237589A0 (en) 2015-04-30
CA2884487A1 (en) 2014-03-20
CN104780781B (zh) 2017-03-01
HK1195856A1 (zh) 2014-11-28
ES2572831T3 (es) 2016-06-02
BR112015005758A2 (pt) 2017-07-04
US20190381077A1 (en) 2019-12-19
EP2708145A8 (en) 2014-09-03
CN104780781A (zh) 2015-07-15
PH12015500545A1 (en) 2015-05-04
DK2708145T3 (en) 2016-07-18
EP2708145B1 (en) 2016-05-04
MY182944A (en) 2021-02-05
EP2708145A1 (en) 2014-03-19
MX369453B (es) 2019-11-08
US10398716B2 (en) 2019-09-03

Similar Documents

Publication Publication Date Title
PH12015500545A1 (en) Methods for modulating corticosterone levels in psychologically stressed individuals
IL263175B (en) Microbiota restoration therapy (mrt) compounds and methods of manufacture
EP4324480A3 (en) Anti-transferrin receptor antibodies and methods of use
EP3838921A3 (en) Antibodies to tau
NZ629697A (en) Human anti-cd27 antibodies, methods and uses
TN2012000414A1 (en) Forms of rifaximin and uses thereof
MX363193B (es) Metodos para tratar la dermatitis atopica mediante la administracion de un antagonista de il-4r.
IN2014DN05885A (es)
MX2014014376A (es) Anticuerpos de anti-biotina y metodos de uso.
MX2017000775A (es) Vacunas de meningococos.
EP3538991A4 (en) PRODUCTION TYPE TEST AND BUSINESS COMPLEX AUDIT SYSTEM
BR112014013172A2 (pt) extratos de maesa japonica e métodos de uso
MX2016004802A (es) Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso.
GB2519697A (en) Golf fitting systems and related methods
WO2013163297A8 (en) Modified glycoproteins
EP3033720A4 (en) Method and system for certification and verification of gemstones
MX2016005854A (es) Anticuerpo anti-her3 alosterico de la neuregulina.
MX2023003000A (es) Formulaciones de liberacion modificada de viloxacina.
EP4241853A3 (en) Compositions for induction of immune response
WO2012151552A3 (en) Keyboard-video-mouse system and method of providing and using the same
MX2019002801A (es) Uso de una composicion farmaceutica que comprende un anticuerpo anti-il-4r en el tratamiento de la dermatitis atopica.
WO2012154609A3 (en) Keyboard-video-mouse system and method of providing and using the same
UA74321U (ru) Способ медицинской реабилитации спортсменов, занимающихся сложнокоординационными и циклическими видами спорта с наличием признаков иммунодефицита и эндогенной интоксикации
AU2014904843A0 (en) Method and system for people to locate and communicate with each other as part of an exclusive social club.
AU2014904728A0 (en) Method and system for people to locate and communicate with each other as part of an exclusive social club.

Legal Events

Date Code Title Description
FG Grant or registration